Navigation Links
Accredited Construct Specific PCR Test for Recently Detected Unapproved GM Flax/Linseed FP967/CDC Triffid Available Through Genetic ID
Date:9/22/2009

AUGSBURG, Germany, September 22 /PRNewswire/ -- Subsequent to the announcement of the EU Rapid Alert System for Food and Feed on 8 September 2009, the German surveillance lab in the state of Baden-Wurttemberg has confirmed the detection of GM linseed/flax variety FP967/CDC Triffid, which is unapproved in the EU.

Additionally, there have been additional EU Rapid Alert announcements regarding the presence of FP967/CDC Triffid in food products distributed to Germany, Italy, Luxembourg, Netherlands, Belgium, and Switzerland. These discoveries have been widely covered by the media globally during the past several days. This unapproved GM flax was detected in a wide variety of flax/linseed products including cereals, bakery products, nut products and seeds.

Having developed the first detection method for construct present in FP967/CDC Triffid, Genetic ID now offers this specific and accredited test worldwide. German surveillance laboratories also use the Genetic ID method to detect this GMO linseed.

This GMO variety originates from the Crop Development Centre Canada at the University of Saskatchewan. Canada supplies approximately 70% of the total flax utilized in the EU annually.

Since neither a safety assessment by the EU nor an application for approval has been submitted for this GMO, the zero tolerance rule applies. This means any raw material or flax/linseed derivative analyzed to be positive for FP967/CDC Triffid is illegal and not marketable in the EU.

Genetic ID developed this test according to the guidelines of the EU Joint Research Centre, and includes this test in its accreditation scope under DIN EN ISO 17025. The JRC has now made the Genetic ID method available to all members of the European Network of GMO Laboratories (ENGL).

Genetic ID provides the food, animal feed and agricultural industry worldwide a full range of GMO testing ser
'/>"/>

SOURCE Genetic ID (Europe) AG
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Enerkem Announces Construction Start on Advanced Energy Research Facility in Edmonton, Alberta
2. Harvest Technologies Announces Completion of Patient Enrollment in its 60 Patient Clinical Trial in India Using Autologous Adult Stem Cells to Treat Patients With Non-Reconstructable Critical Limb Ischemia
3. Vega Picks Tennessee Firm to Assist with Construction of Biomass Plant in Georgia
4. Sinovac Completes Construction of H1N1 Virus Seed Bank
5. Secret of sandcastle construction could help revive ancient building technique, researchers say
6. Sandia researchers construct carbon nanotube device that can detect colors of the rainbow
7. NanoLogix Begins Construction of Production Facility for Medical Test Kits
8. Mach One Subsidiary Modular Process Constructors LLC Changes Name to MPS BioPharm to Better Reflect its Vision
9. New Generation Biofuels Completes Construction of Baltimore Facility
10. Asbestos, Pharmaceutical Liability, Construction Defects, Nanotech: Covered by Targeted CLE Teleconferences
11. Max Planck Institute of Biochemistry Uses MathWorks Tools in Its Quest to Cure Cancer : Institute Accelerates Reconstruction of Key Protein Complexes Using MATLAB and Parallel Computing Toolbox
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2015)... Warren, NJ (PRWEB) May 22, 2015 ... a new white paper that explores the potential of ... industries. The white paper was developed to help life ... they can leverage data to gain critical business insights. ... generated large amounts of data driven by patient profiling, ...
(Date:5/21/2015)... May 21, 2015 Seventh Wave Laboratories, ... and efficacy of pharmaceutical products and medical devices, announced ... MO 63043, a 50,000 sq. ft. building more than ... enable strategic growth. Facility renovations will begin immediately and ... space will occur in September. , “We are ...
(Date:5/21/2015)... May 21, 2015  Prima Biomed Ltd. (NASDAQ: ... striving to become a leader in the development of ... that the final CVac data from the Phase II ... trend for a clinically meaningful improvement in Overall Survival ... patients. In the group of second remission ...
(Date:5/21/2015)... -- Imagine being able to probe and ... others. Being able to read faces and enjoy genuine ... anticipate their thoughts and actions like never before. Use ... create unique abstract paintings and video, or, play a ... first-person-shooter as it creates action, dialog, and outcomes based ...
Breaking Biology Technology:New White Paper Explores the Potential of Big Data Analytics in Life Sciences and Healthcare 2Seventh Wave Laboratories Purchases Building for Expansion, Upcoming Move 2Seventh Wave Laboratories Purchases Building for Expansion, Upcoming Move 3Correction Continues after Big Move - BrokerBank Securities, Inc. 25 Days to Meet ARGUS - The World's First Contactless Emotions Scanner 2
... ,Arpida Ltd (SWX: ARPN) presented a large body ... iclaprim at the 47th annual Interscience,Conference on Antimicrobial ... major scientific conference where thousands of scientists and,clinicians ... the latest,developments in the field of infectious diseases. ...
... in ... platelets, WORCESTER, Mass., Sept. ... bacterial contaminants in,blood cells and tissue, has received 510 (k) clearance for ... This provides,Verax authorization to market the device, which cuts the detection time ...
... In a sea of,streamers this morning, the most ... contribution to Florida Children,s Hospital from Walt Disney,World and ... banner,from the 11- story hospital, The Walt Disney Company ... and laid the foundation for,the "Children,s Hospital of the ...
Cached Biology Technology:Arpida Presents Preclinical and Clinical Data on Iclaprim at ICAAC 2Arpida Presents Preclinical and Clinical Data on Iclaprim at ICAAC 3Arpida Presents Preclinical and Clinical Data on Iclaprim at ICAAC 4Verax Biomedical Receives 510 (k) Clearance from FDA for Platelet PGD Test 2Verax Biomedical Receives 510 (k) Clearance from FDA for Platelet PGD Test 3Florida Children's Hospital and Disney Unite to Create Magical Pediatric Hospital 2Florida Children's Hospital and Disney Unite to Create Magical Pediatric Hospital 3Florida Children's Hospital and Disney Unite to Create Magical Pediatric Hospital 4
(Date:5/11/2015)... , May 11, 2015 Curemark LLC, a ... start of a new Phase III double blind, randomized, ... novel formulation, CM-AT, on all children ages 3-8 with ... FDA Phase III double blinded clinical trial for CM-AT ... levels of the digestive enzyme chymotrypsin. This new trial ...
(Date:5/5/2015)... Conn. , May 5, 2015, NXT-ID, Inc. ... authentication company focused on the growing mobile commerce market, reminds ... Company,s Chief Technology Officer, is presenting  at CARTES SECURE CONNEXIONS ... May 5-7, 2015. The three-day conference is ... David is speaking in is themed Global Fraud: Where ...
(Date:4/20/2015)... April 20, 2015 Huntington Memorial Hospital is ... implant a new miniaturized, wireless monitoring sensor to manage ... first and only FDA-approved heart failure monitoring device that ... used by physicians to manage heart failure. ... implanted in the pulmonary artery (PA) during a non-surgical ...
Breaking Biology News(10 mins):Curemark, LLC, Launches New Phase III Trial in Expanded Population of Children with Autism 2NXT-ID, Inc.'s CTO, David Tunnell, Presents at CARTES SECURE CONNEXIONS AMERICA 2015 Today in Washington DC. 2NXT-ID, Inc.'s CTO, David Tunnell, Presents at CARTES SECURE CONNEXIONS AMERICA 2015 Today in Washington DC. 3Huntington Memorial Hospital Becomes First in the San Gabriel Valley to Offer Patients a New Heart Failure Monitoring Solution 2Huntington Memorial Hospital Becomes First in the San Gabriel Valley to Offer Patients a New Heart Failure Monitoring Solution 3
... investigating the carbon sink capacity of northern terrestrial ... carbon uptake period (CUP) has on average decreased ... uptake of northern ecosystems is decreasing in response ... January 3rd, in the journal Nature. The carbon ...
... Jefferson University Hospital and Jeffersons Kimmel Cancer Center have ... effect high dose vitamin C has on non-Hodgkin lymphoma ... Medicine and Kimmel Cancer Center in conjunction with the ... of vitamin C can slow the progression of the ...
... BioScience includes a special section entitled Managing for ... in the section highlight different aspects of attempts ... ecosystem-based management of coastal marine areas. ... marine ecosystems provide has grown in recent years, ...
Cached Biology News:Jefferson scientists studying the effects of high-dose vitamin C on non-Hodgkin lymphoma patients 2Resilience concepts poised to aid management of coastal marine ecosystems 2
iNOS/NOS Type II Purified Anti-Mouse, Anti-Rat, Anti-Human clone Polyclonal, Isotype Rabbit Ig, 150 µg Consult technical datasheet for details....
... Bio-Plex suspension array system, 100-240 V, uses ... simultaneous quantitative analysis of up to 100 ... well. The suspension array is composed of ... of which may be conjugated with a ...
... The high-throughput fluidics (HTF) system, 100-240 ... Bio-Plex suspension array system that automates delivery ... fluid into the Bio-Plex array reader. The ... a nonpressurized bulk sheath container to constantly ...
Cell Culture Flask, 75 cm, nontreated polystyrene...
Biology Products: